MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients

<p>Dr. Philipp Karschnia discusses his paper, "Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Primary CNS Lymphoma Patients Treated With Methotrexate-Based Regimens".</p> <p>Show references: https://n.neurology.org/content/early/2023/08/01/WNL.0000000000207670</p>